June 18, 2023
2 min watch
Save
VIDEO: Reimbursement available for Iheezo ocular anesthetic
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Key takeaways:
- Iheezo is an FDA-approved ocular anesthetic.
- It is reimbursable by Medicare and commercial insurance.
SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, William F. Wiley, MD, speaks about Iheezo, the first ocular anesthetic approved by the FDA in nearly 14 years.
“It has been a great addition to our protocol for cataract surgery, but it can also be used for any ocular surgery,” he said.
Iheezo (chloroprocaine hydrochloride ophthalmic gel 3%, Harrow) has a permanent J-code that will enable reimbursement by Medicare and many commercial insurances.
In the clinical trials, no patient administered Iheezo needed supplemental anesthesia to complete the procedure.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Wiley reports consulting for Harrow.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.